Prollenium Medical Technologies Inc.
Smitha Rency has extensive experience in quality and regulatory affairs, currently serving as a Quality and Regulatory Affairs Specialist at Prollenium Medical Technologies Inc. since August 2020, after progressing through various roles including Sr. Quality and Regulatory Associate and Quality and Regulatory Affairs Associate. Prior to Prollenium, Smitha worked at Biosensia from October 2013 to March 2019 as a Quality Assurance Specialist and Product Development Scientist, where responsibilities included quality system documentation, vendor approval management, and participation in failure investigations. Earlier experience includes a role as a Microbiology Analyst at Ernakulam Medical Center and as a Guest Lecturer at Pazhassi Raja College. Smitha holds a Post Graduate Diploma in Quality Assurance and Regulatory Affairs, a Master's degree in Applied Microbiology, and a Bachelor's degree in Applied Microbiology from Bharathiar University, as well as a Diploma Certificate in Pharmaceutical and Medical Device Operations from Technological University Dublin.
This person is not in the org chart
Prollenium Medical Technologies Inc.
Prollenium Medical Technologies Inc. is a fast-growing Canadian manufacturer and distributor of premium HA dermal filler. We are proud to address all of our client's needs through streamlined medical device innovation. Prollenium is able to ensure a continual flow of creation, unique ideas, and a steady pipeline of new and exciting products that provide safe and effective results. US FDA, Health Canada, and CE approvals, over 4 million syringes in the Revanesse product line have been sold to 80+ countries world-wide. Prollenium is the only manufacturer of Hyaluronic Acid dermal fillers in North America. Join our dedication to innovation.